Validation of a four-primer real-time PCR as a diagnostic tool for single and mixed Plasmodium infections  by Cnops, L. et al.
Validation of a four-primer real-time PCR as a diagnostic tool for single
and mixed Plasmodium infections
L. Cnops, J. Jacobs and M. Van Esbroeck
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
Abstract
Although microscopy remains the reference standard for malaria diagnosis, molecular tools are attracting increasing interest. To improve
the detection of mixed infections, we developed a four-primer real-time PCR with four Plasmodium species-speciﬁc forward primers,
based on the pan-primer design with universal Plasmodium primers as described previously. After validation for analytical sensitivity, spec-
iﬁcity and reproducibility, the four-primer PCR was evaluated on 351 blood samples from patients presenting at the outpatient clinic of
the Institute of Tropical Medicine (Belgium). With the four-primer PCR, we identiﬁed 188 Plasmodium falciparum (Pf), 54 Plasmodium vivax
(Pv), 52 Plasmodium ovale (Po) and 13 Plasmodium malariae (Pm) single infections, 27 mixed infections (14 Pf + Pm; 12 Pf + Po; one
Pv + Pm) and 17 negative specimens. We found lower cycle threshold values than with the pan-primer PCR, with a mean difference of
2.23, a higher analytical sensitivity (in asexual parasites/lL: Pf/Pv, 0.02; Po, 0.004; Pm, 0.006) and 15 extra mixed infections. As compared
with microscopy, 17 extra mixed infections were detected and Plasmodium species were identiﬁed in four microscopy-positive samples
in which species identiﬁcation was not possible. Additionally, the PCR corrected 13 species mismatches between Po and Pv, and in 11
cases detected Pf as a second species that was not identiﬁed by microscopy and in ﬁve of them was not detected by rapid diagnostic
tests (RDTs). PCR conﬁrmed the presence of Pf in 30/46 histidine-rich protein-2-positive samples that were microscopy-negative. We
conclude that the presently developed four-primer real-time PCR is complementary to standard malaria diagnostic tests in clinical labo-
ratories, with an added value for simultaneous identiﬁcation of the four Plasmodium species and the detection of mixed infections.
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Introduction
Malaria is the most important parasitic infection worldwide.
Because of the increasing amount of travel to tropical desti-
nations, the number of malaria cases being imported to Eur-
ope is rising [1]. Adequate identiﬁcation of the four
Plasmodium species, which differ greatly in their biology and
clinical manifestations, is important for successful treatment.
In cases of co-infection, diagnosis and subsequent treatment
is even more complicated [2–4].
Species differentiation is possible by microscopic blood
smear examination when conducted by trained and experi-
enced staff. However, low levels of parasitaemia, mixed Plas-
modium infections, altered morphology of parasites following
(self)treatment and poor smear quality challenge the abilities
of even the most skilled microscopists. Some problems can
be overcome by the use of rapid diagnostic tests (RDTs),
although they have lower sensitivities at low parasite densi-
ties and a limited capacity for non-Plasmodium falciparum (Pf)
and mixed-species identiﬁcation [5–9]. Accordingly, molecu-
lar techniques can be applied to resolve discordant results
or as reference methods [10]. Many studies have demon-
strated increased malaria diagnosis and corrected species
identiﬁcations by PCR, especially for non-Pf and mixed infec-
tions [2,4,11–13].
Several real-time PCR formats have been successfully
applied for malaria diagnosis in non-endemic settings [11,14–
17]. However, not all formats were designed to differentiate
between the four Plasmodium species, and these appear to
be less suitable for the detection of mixed infections than
are conventional nested-PCR formats, owing to competitive
inhibition [18]. Indeed, universal Plasmodium primers generate
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competition for PCR reagents in cases of mixed infection,
and might give false-negative results for the minor species
[14,19]. To avoid this competition, we developed a new real-
time PCR based on the PCR of Rougemont [14], which we
have used before. After validation of the new PCR—hereaf-
ter referred to as four-primer PCR—we analysed 351 clinical
samples in comparison with the pan-primer PCR (adapted
from Rougemont) [14] and with standard microscopy.
Materials and Methods
DNA extraction
DNA was extracted from 200 lL of blood with the Qiagen
DNA mini kit (Qiagen Benelux, Venlo, The Netherlands),
according to the manufacturer’s guidelines. DNA was eluted
with 200 lL of elution buffer (Qiagen).
18S rRNA real-time PCR
For the pan-primer PCR, the same universal Plasmodium pri-
mer set (plasmo1 and plasmo2) and four species-speciﬁc
probes (Biolegio, Nijmegen, The Netherlands) (Fig. 1) as
previously described were used [14], except for the Vivp-
robe, which was made 12 bp shorter and contained a
minor groove binder modiﬁcation. Two duplex reactions
were run simultaneously. One 25-lL duplex reaction mix
(Pf/Plasmodium vivax (Pv)) contained 5 lL of DNA, Quanti-
tec mix (Qiagen Benelux), 200 nM plasmo1 and plasmo2,
100 nM Falcprobe and 200 nM Vivprobe. In the other
duplex reaction mix (Plasmodium malariae (Pm)/Plasmodium
ovale (Po)), besides 5 lL of DNA, 1· Quantitec mix, and
500 nM plasmo1 and plasmo2, 320 nM Ovaprobe, 200 nM
Malaprobe and 1 mM MgCl2 were added. The PCR pro-
gram consisted of an initial step of 15 min at 95C, fol-
lowed by 50 cycles of 5 s at 95C, 30 s at 58C and ﬁnally
30 s at 72C.
For the four-primer PCR, newly designed species-speciﬁc
forward (FW) primers (FWfal, FWviv, FWmal, FWova; Biolegio)
were used in combination with the species-speciﬁc probes
and reverse plasmo2 primer (Fig. 1). Two duplex reactions
were run in parallel, each containing 200 nM primers and
probes, except for 100 nM FWviv primer and Vivprobe, with
plasmo1 
TAAAATACTTCCATTAATCAAGAACGAAAGTTAAGGGAGTGAAGACGATC   1067
TAAAATACTTCCATTAATCAAGAACGAAAGTTAAGGGAGTGAAGACGATC   1079
TAAAATACTTCCATTAATCAAGAACGAAAGTTAAGGGAGTGAAGACGATC   1398
TAAAATACTTCCATTAATCAAGAACGAAAGTTAAGGGAGTGAAGACGATC   1106
**************************************************
Species-specific. FW primers 
AGATACCGTCGTAATCTTAACCATAAACTATGCCGACTAGGTGTTGGATG   1117
AGATACCGTCGTAATCTTAACCATAAACTATGCCGACTAGGTTTTGGATG   1129
AGATACCGTCGTAATCTTAACCATAAACTATGCCGACTAGGCTTTGGATG   1448
AGATACCGTCGTAATCTTAACCATAAACTATGCCGACTAGGTGTTGGATG   1156
*****************************************  ******* 
Species-specific. probes  
AAAGTGTTAAAAATAAAAG------TCATCTTTCGAGGTGA--CTTTTAG   1159
AAAGATTTTTAAATAAGAAA------ATTCCTTTCGGGGAAATTTCTTAG   1173
AAAGATTTTAAAATAAGAA------TTTTCTCTTCGGAGTTTATTCTTAG   1492
ATAGAGTAAAAAATAAAAGAGACATTCATATATATGAGTGTTTCTTTTAG   1206
* **  *   ****** *          *   *           * **** 
plasmo2
ATTGCTTCCTTCAGTACCTTATGAGAAATCAAAGTCTTTGGGTTCTGGGG   1209
ATTGCTTCCTTCAGTACCTTATGAGAAATCAAAGTCTTTGGGTTCTGGGG   1223
ATTGCTTCCTTCAGTGCCTTATGAGAAATCAAAGTCTTTGGGTTCTGGGG   1542
ATAGCTTCCTTCAGTACCTTATGAGAAATCAAAGTCTTTGGGTTCTGGGG   1256
** ************ ********************************** 
FIG. 1. Primer and probe sequences. Partial alignment of the Plasmodium falciparum (Pf) (accession number M19172; bp 1067–1209), Plasmodium
ovale (Po) (accession number L48987; bp 1079–1223) Plasmodium vivax (Pv) (accession number X13926; bp 1398–1542) and Plasmodium malariae
(Pm) (accession number AF488000; bp 1106–1256) 18S rRNA gene around the region of selected primers and probes. The pan-primer PCR uses
universal Plasmodium genus forward (FW) (plasmo1) and reverse (plasmo2) primers (bold italic) in combination with four species-speciﬁc probes
(Falcprobe, Vivprobe, Malaprobe and Ovaprobe) (grey highlights). In the four-primer PCR, four species-speciﬁc FW primers (underlined) are
used instead of plasmo1, resulting in shorter amplicons (Pf, 100 bp; Pv, 105 bp; Pm, 110 bp; Po, 105 bp).
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1· Perfecta qPCR Supermix (Quanta Biosciences, Gaithers-
burg, MD, USA). The PCR was run for 2 min at 95C, and
this was followed by 50 cycles of 15 s at 95C and 60 s at
60C. FW primer design was veriﬁed with Integrated DNA
Technology Oligo Analyzer software (v3.1) (http://eu.idtdna.
com/analyzer/Applications/OligoAnalyzer/).
PCRs were run on a SmartCycler II (Cepheid Benelux,
Bouwel, Belgium). In every run, the non-template control
was negative (cycle threshold (Ct) = 0) and the positive con-
trol for each species was positive.
Validation of the four-primer PCR
Speciﬁcity. Primer speciﬁcity was checked in silico by BLAST
analysis (http://blast.ncbi.nlm.gov/Blast.cgi) and by gel electro-
phoresis on PCR products. The analytical speciﬁcity of the
PCR was tested on six non-Plasmodium blood parasites
(Leishmania donovani, Trypanosoma cruzi, Trypanosoma brucei
gambiensis, Loa loa, Aspergillus and Pneumocystis (based on
[14]), and the diagnostic speciﬁcity on 30 negative controls
derived from individuals suspected of having malaria but with
no evidence of Plasmodium infection as demonstrated by
microscopy and RDTs.
Analytical sensitivity. The detection limit was determined on
serial ten-fold dilutions of high-parasitaemia clinical blood
samples of the four Plasmodium species. From each 1/10
blood dilution, DNA was extracted, and the highest dilution
with a positive signal indicated the detection limit.
Repeatability and reproducibility. The variation in Ct values was
determined for each Plasmodium species in a sample that was
processed eight times within the same run (repeatability) or
ﬁve times in different runs (reproducibility).
Clinical samples
The panel of clinical samples collected between 1995 and
2009 consisted of EDTA-anticoagulated blood samples
(n = 351) from patients who presented at the outpatient
clinic of the Institute of Tropical Medicine (ITM) Antwerp,
Belgium, or sent by national laboratories for malaria conﬁr-
mation at the Central Laboratory of Clinical Biology of the
ITM (accredited according to ISO15189:2007). PCR analysis
was performed between January 2007 and January 2010,
prospectively on fresh samples (stored for a maximum of
1 week at 4C) for routine diagnosis, or retrospectively on a
panel of frozen samples (stored at )70C). Only the ﬁrst
sample per patient was included in this study. Molecular diag-
nosis was performed with pan-primer PCR until August
2009, and from September 2009 the new four-primer PCR
was applied.
Evaluation of clinical samples
Standard microscopic analysis was carried out on Giemsa-
stained smears, and parasite density was expressed as the
number of asexual parasites/lL [5,7].
For antigen detection, an RDT for qualitative detection of
Pf histidine-rich protein-2 (HRP-2) was performed according
to the manufacturer’s instructions. Until 2007, the Now
Malaria test (Binax, Scarborough, ME, USA), which also
detects pan-species aldolase, was used. From 2008, the SD-
FK60 Malaria Ag Pf/pan test (Standard Diagnostics, Hagal-
Dong, Korea), which detects HRP-2 and pan-species parasite
lactate dehydrogenase, was used. All specimens positive by
microscopy (n = 305) or RDT alone (n = 46) were examined
with both real-time PCRs on the same DNA extract.
Further analysis of discrepant results
Discrepant results between the PCR methods or between
microscopy and PCR were assessed with an additional RDT
for Pv (SD-FK70; Standard Diagnostics) targeting the Pv-spe-
ciﬁc parasite lactate dehydrogenase, by external real-time
PCR analysis for species conﬁrmation at the laboratory of
Leiden (LUMC, Leiden, The Netherlands) [17], or by supple-
mentary information obtained from species identiﬁcation in a
treatment follow-up sample.
Data analysis
Improved DNA detection was determined by subtracting Ct
values measured by the two PCRs, and is indicated by DCt.
Theoretically, the amplicon amount doubles every cycle (i.e.
increases by 1 log2), and one DCt therefore corresponds to
a two-fold increase in analytical sensitivity. Statistical differ-
ences between logarithmic Ct values of the PCRs were
determined by paired t-test analysis. The yield in mixed infec-




The newly developed FW primers were speciﬁc for each of
the four Plasmodium species (Fig. 1) and were located more
closely to the probe hybridization positions, resulting in
shorter amplicon lengths. Integrated DNA Technology Oligo
analysis approved no self-dimerization or heterodimerization
with the reverse primers and probes. BLAST analysis indi-
cated 100% query coverage and maximum identity with the
correlated species. Gel electrophoresis provided a single
band of the expected length, and no signal in the non-tem-
plate control.
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PCR validation
After optimization of the reaction products and programme,
the PCR was validated. No ampliﬁcation was seen in six
non-Plasmodium controls or 30 negative control samples.
Analytical sensitivity tests on serial dilutions demonstrated
detection limits of 0.02, 0.02, 0.004 and 0.006 parasites/lL
for Pf, Pv, Po and Pm, respectively, which corresponds to
approximately one to four asexual parasites per unit of
blood volume (200 lL). Repeatability and reproducibility
testing revealed coefﬁcients of variation lower than 0.8% and
1.3%, respectively, for all Plasmodium species.
Microscopic and PCR analysis of clinical samples
Table 1 shows malaria diagnosis for 351 whole blood samples
by standard microscopy, pan-primer PCR and four-primer
PCR. Overall, more malaria cases were diagnosed with PCR
than with microscopy. Among 351 samples, 305 (86.9%) were
positive by microscopy, and 331 (94.3%) and 334 (95.2%) with
the pan-primer PCR and four-primer PCR, respectively. The
numbers of mixed infections detected by microscopy, pan-pri-
mer PCR and four-primer PCR were 10, 12 and 27, respec-
tively. The signiﬁcant increase in yield of mixed infections with
the four-primer PCR as compared with the pan-primer PCR
(p <0.05) and microscopy (p £0.01) involved both Pf/Pm and
Pf/Po (14 and 12, respectively). In four samples, identiﬁcation
was possible with both PCRs but not by microscopy (Table 1).
Comparison of the four-primer PCR and pan-primer PCR
The mean, minimum and maximum Ct values of both PCRs
were calculated per Plasmodium species (Table 2). The maxi-
mum Ct values were clearly lower with the four-primer PCR
than with the pan-primer PCR. In addition, for all samples,
signiﬁcantly lower Ct values (p <0.0001) were found with
the four-primer PCR, which is indicative of better DNA
detection. On average, the largest improvement was seen
for Pm (Table 2). Overall, the mean increase in DCt value
for all species was 2.23 (±0.25), corresponding to a more
than four-fold increased analytical sensitivity.
Table 3 shows concordant results between both PCR
methods for 183 Pf, 54 Pv, 52 Po and 13 Pm single infec-
tions, 12 mixed infections and 15 negative samples. In con-
trast, for 15 samples, DNA ampliﬁcation of two species was
seen with the four-primer PCR but not with the pan-primer
PCR (Table 3, footnotes b–e). In those cases, Pf was addi-
tionally recognized in seven co-infections with Pm and in
two co-infections with Po. All mixed infections could be con-
ﬁrmed by additional tests, except for three patients.
Five samples that were Pf-positive with the four-primer
PCR (Ct values >38.8), were missed with the pan-primer
PCR (Table 3, footnote a). All ﬁve samples were HRP-2-posi-
tive and in one sample six parasites/lL were seen with
microscopy. For two samples, only the pan-primer PCR (Ct
values >40.5) and RDT were Pf-positive, microscopy and the
four-primer PCR giving negative results (Table 3, footnote f).
Comparison of the four-primer PCR and microscopy
Table 4 shows the four-primer PCR and microscopy results.
Single species identiﬁcations showed concordant results for
158 Pf, 49 Pv, 41 Po and 12 Pm samples. In nine microscopi-
cally detected mixed infections, DNA of the same two spe-
cies was co-ampliﬁed (four Pf + Pm; four Pf + Po; one
Pv + Pm). Sixteen HRP-2-positive samples were negative by
both PCR and microscopy (Table 4, footnote j).
Species identiﬁcation by microscopy was not possible in
four cases, although parasites were seen. PCR analysis
revealed Pf (n = 1), Pv (n = 1) and Po (n = 2) in those sam-
ples.
TABLE 1. Species distribution of Plasmodium spp. according








Total 351 351 351
Negative 46 (13.1) 20 (5.7) 17 (4.8)
Positive 305 (86.9) 331 (94.3) 334 (95.2)
Single 291 (95.4) 319 (96.4) 307 (91.9)
Pf 165 (54.1) 191 (57.7) 188 (56.3)
Pv 58 (19.0) 54 (16.3) 54 (16.2)
Pm 48 (15.7) 54 (16.3) 52 (15.6)
Po 20 (6.6) 20 (6.0) 13 (3.9)
Mixed 10 (3.3) 12 (3.6) 27 (8.1)
Pf/Pm 5 (1.6) 6 (1.8) 14 (4.2)
Pf/Po 4 (1.3) 5 (1.5) 12 (3.6)
Pv/Pm 1 (0.3) 1 (0.3) 1 (0.3)
Unknown
? 4 (1.3) 0 (0.0) 0 (0.0)
Total 351 351 351
Pf, Plasmodium falciparum; Pm; Plasmodium malariae; Po, Plasmodium ovale; Pv,
Plasmodium vivax.
Percentages of negative and positive samples are given as proportions of the
total number (n = 351). Percentages of species (single, mixed and unknown) are
given as proportions of the number of positive samples.
TABLE 2. Cycle threshold (Ct) values of the pan-primer
PCR and four-primer real-time PCR for the four Plasmo-
dium species
Pan-primer PCR Four-primer PCR
Mean DCta
(±95 CI)Mean (min.–max.) Ct Mean (min.–max.) Ct
Pf 27.83 (17.61–44.94) 26.49 (15.62–42.39) 1.92 (0.25)
Pv 26.86 (20.37–36.84) 25.59 (19.67–34.36) 1.27 (0.40)
Po 30.59 (24.24–49.29) 28.68 (22.17–39.79) 2.96 (0.71)
Pm 33.81 (25.82–49.47) 27.95 (24.13–34.76) 4.87 (1.43)
Pf, Plasmodium falciparum; Pm; Plasmodium malariae; Po, Plasmodium ovale; Pv, Plas-
modium vivax.
aMean of the differences between Ct values of both real-time PCRs for each
sample (±95% CI).
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Species mismatches were seen for 13/103 (12.6%) Po or
Pv infections (Table 4, footnotes b and c). Examination with
an additional Pv-speciﬁc RDT or external PCR analysis con-
ﬁrmed the identiﬁcations in favour of the PCR.
For 17 samples (Table 4, footnotes e–h), microscopic
examination resulted in single species identiﬁcations, and PCR
detected two species as conﬁrmed by additional tests on eight
samples in favour of the PCR. Pf was missed by microscopy in
11 samples, and it was co-ampliﬁed (eight Pf + Pm; three
Pf + Po) as a minor species with Ct values >33. The presence
of Pf was conﬁrmed by RDT in 6/11 samples.
In one Pf/Pm mixed infection diagnosed by microscopy, Pf
was not detected by four-primer PCR and external PCR or
RDT analysis. For another sample, no DNA ampliﬁcation
was seen, and microscopy demonstrated 13 parasites/lL for
Pf. Finally, 30 of the 46 microscopically negative but HRP-2-
positive samples (Table 3, footnotes h and i) gave a positive
PCR signal, with a mean Ct value of 36.3 (range: 27.3–42.4).
Discussion
This study demonstrates that the four-primer real-time PCR
is a powerful tool for malaria diagnosis. It performed excel-
lently with regard to speciﬁcity, sensitivity and reproducibil-
ity, and, unlike in other studies [14–17,20,21], was validated
TABLE 3. Cross-tabulation of species identiﬁcations generated by both real-time PCR methods
Pan-primer PCR
Pf Pv Po Pm Pf + Pm Pf + Po Pv + Pm Negative Total




Pf + Pm 1b 7c 6 14
Pf + Po 5d 2e 5 12
Pv + Pm 1 1
Negative 2f 15 17
Total 191 54 54 20 6 5 1 20 351
Pf, Plasmodium falciparum; Pm; Plasmodium malariae; Po, Plasmodium ovale; Pv, Plasmodium vivax.
aPf conﬁrmed by histidine-rich protein-2 (HRP-2)-positive rapid diagnostic test (RDT) (n = 4) and microscopy, and HRP-2-positive RDT (n = 1).
bPm in mixed infection conﬁrmed by microscopy.
cPf in mixed infection conﬁrmed by HRP-2-positive RDT (n = 5) and/or microscopy (n = 1). For two samples, there was no conﬁrmation for Pf by additional tests.
dPo in mixed infection conﬁrmed by microscopy (n = 1) or a follow-up sample (n = 3). For one sample, there was no conﬁrmation for Po by additional tests.
ePf in mixed infection conﬁrmed by HRP-2-positive RDT (n = 2).
fPf conﬁrmed by HRP-2-positive RDT (n = 2).
TABLE 4. Microscopic vs. four-primer real-time PCR analysis
Microscopy
Pf Pv Po Pm Pf + Pm Pf + Po Pv + Pm ? Negative Total
Four-primer PCR Pf 158 1 29a 188
Pv 49 4b 1 54
Po 9c 41 2 52
Pm 12 1d 13
Pf + Pm 2e 8f 4 14
Pf + Po 4g 3h 4 1i 12
Pv + Pm 1 1
Negative 1 16j 17
Total 165 58 48 20 5 4 1 4 46 353
Pf, Plasmodium falciparum; Pm; Plasmodium malariae; Po, Plasmodium ovale; Pv, Plasmodium vivax.
Bold type indicates that Pf was not identiﬁed by microscopy (n = 12) or PCR (n = 1, see footnote j), and was conﬁrmed by a histidine-rich protein-2 (HRP-2)-positive rapid
diagnostic test (RDT) (n = 7).
aHRP-2-positive samples (n = 29), and conﬁrmation of Pf in treatment follow-up sample (n = 1).
bConﬁrmation of Pv by Pv-speciﬁc RDT (n = 3) and/or external PCR (n = 2).
cConﬁrmation of Po by negative Pv RDT (n = 5; parasite density >2500 parasites/lL) and external PCR (n = 4).
dNo conﬁrmation by RDTs for the Pf seen by microscopy, despite the high parasite density (2100 parasites/lL).
eNo additional conﬁrmation for Pm.
fConﬁrmation of Pf by HRP-2-positive RDT (n = 4), by external PCR (n = 1) or based on a follow-up sample (n = 1); for two samples there was no conﬁrmation for Pf by
additional tests.
gConﬁrmation of Po by follow-up sample (n = 2); no conﬁrmation for Po by additional tests (n = 2).
hConﬁrmation of Pf by HRP-2-positive RDT (n = 2).
iConﬁrmation by follow-up sample and presence of Pf by HRP-2-positive RDT.
jHRP-2-positive samples.
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on a large number of positive clinical samples in a non-ende-
mic setting. Our real-time format simultaneously detects four
Plasmodium species with a turn-around time of <3 h, which is
faster than the simplex or nested-PCR methods used by oth-
ers [2,18–20,22–26].
We showed that the four-primer PCR performed better
than the pan-primer PCR. First, we consistently obtained
lower Ct values, resulting in a more than four-fold increased
analytical sensitivity. Second, the detection limit for all spe-
cies was lower than described for the pan-primer PCR (0.2–
2 parasites/lL) [14] and other real-time PCR methods
[16,20,21,25,26]. Third, more mixed infections were
detected. The improved ampliﬁcation is mainly attributable
to the limited competition for primers, demonstrating that
accurate primer and probe design is essential during PCR
development.
Many studies have reported that the actual malaria preva-
lence estimated by PCR is higher than previously determined
by microscopy [2,3,13,22]. A report based on 13 studies that
compared microscopy with PCR [11] described 11% more
imported malaria cases, and we obtained 8.3% more malaria
diagnoses.
PCR is clearly of value for species identiﬁcation in cases
where microscopy fails, as demonstrated in this article. First,
PCR corrected 11.4% of Po/Pv cases misdiagnosed by
microscopy, a typical species mismatch that has also been
seen by others [3,4,11,12,27]. Second, species identiﬁcation
was possible by PCR but not by microscopy in 1.3% of the
microscopy-positive samples. One identiﬁcation revealed Pf,
the most hazardous species. Comparable conclusions were
drawn in a report based on ten studies comparing thin slide
examinations and PCR, in which 17.2% microscopically deter-
mined identiﬁcations were corrected by PCR, mainly for
non-Pf malaria, and less so for Pf malaria [11–15].
It is of note that in one microscopy-positive sample, no
PCR ampliﬁcation was seen, probably because of DNA deg-
radation or inhibition of the PCR ampliﬁcation. The mainly
retrospective nature of our study did not allow exploration
of all discordant results.
The most remarkable result from this study is the capacity
of the four-primer PCR to detect mixed infections. Gener-
ally, the proportion of mixed infections detected by molecu-
lar methods in non-endemic settings is higher than by
microscopy, varying from 5% up to 12% [3,12,18,19,27,28].
In this study, a two-fold higher prevalence of mixed infec-
tions was found as compared with microscopy, and even as
compared with the pan-primer PCR. This is of concern par-
ticularly in cases of missed Pf co-infections, which have sub-
stantial implications for the treatment and clinical course of
the disease [2,11–13,28,29]. In this study, Pf was identiﬁed by
the four-primer PCR as the second species in 11 mixed
infections. Five of these were missed by RDT analysis and
microscopy, probably because of the low parasite density.
We have described PCR analysis of specimens that were
picked up by microscopy or by RDT alone. The limitation of
this approach is that no negative samples were analysed, so
we cannot calculate the increase in sensitivity by analysing all
samples of patients suspected of having malaria with PCR
without regarding microscopy or RDT results, although we
have anecdotal evidence for it.
Analysis of samples that were positive only by RDT illus-
trates PCRs capacity to demonstrate the presence of Pf par-
asites in (partly) treated patients. In about two-thirds of
samples that were only HRP-2-positive, PCR conﬁrmed Pf
and thus excluded the false-positive reactions that can be
obtained with RDTs [5–9].
PCR is also of value for species identiﬁcation in (partly)
treated patients with non-Pf or mixed infections that are
detected but not identiﬁed by RDTs. The role for PCR in
treatment follow-up and prediction of treatment failure
needs further research. Altogether, we conclude that the
four-primer real-time PCR allows identiﬁcation of the four
Plasmodium species in single and mixed infections, and is of
added value in reference settings.
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